Jazz Pharmaceuticals plc 13F holders
Of the 44 funds followed here, 8 reported a position in Jazz Pharmaceuticals plc in a 13F for the quarter ended 30 June 2026. The largest: FMR LLC, 4.6 million shares worth $1.11 billion, 0.0% of its reported book. Sold out: Alyeska.
| Fund | Shares | Value | Of its book | Change on the quarter | Status | Quarter ended | Filing |
|---|---|---|---|---|---|---|---|
| FMR LLC | 4,609,326 | $1.11 billion | 0.0% | +2,333,564 | added | 30 June 2026 | 13F |
| Geode Capital Management | 1,483,031 | $357.4 million | 0.0% | +245,414 | added | 30 June 2026 | 13F |
| Citadel Advisors | 1,085,676 | $261.6 million | 0.0% | -258,268 | trimmed | 30 June 2026 | 13F |
| Millennium Management | 763,880 | $184.1 million | 0.1% | -524,031 | trimmed | 30 June 2026 | 13F |
| Norges Bank | 656,843 | $158.3 million | 0.0% | held | 30 June 2026 | 13F | |
| Renaissance Technologies | 562,073 | $135.4 million | 0.2% | -257,301 | trimmed | 30 June 2026 | 13F |
| Two Sigma Investments | 400,212 | $96.4 million | 0.1% | +380,612 | added | 30 June 2026 | 13F |
| Point72 Asset Management | 8,100 | $2.0 million | 0.0% | -356,334 | trimmed | 30 June 2026 | 13F |
| Alyeska | 0 | $0 | 0.0% | -411,015 | exited | 30 June 2026 | 13F |
Value is what the fund reported.
Read more
Change is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.Schedule 13D and 13G filed on the name, last twelve months
| Filed | Schedule | Who | Holding | Of the class | Event date | Rule or purpose | Filing |
|---|---|---|---|---|---|---|---|
| 6 August 2026 | 13G | Fmr Llc and 3 others | 4.7 million | 7.4% | 30 June 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 30 April 2026 | 13G | Vanguard Capital Management and 1 other | 3.1 million | 5.0% | 31 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 27 March 2026 | 13G/A | The Vanguard Group and 1 other | 0 | 0.0% | 13 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read more
Amendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short.Fails to deliver
| Settlement date | Shares failed | Price | File |
|---|---|---|---|
| 19 August 2026 | 7,400 | $253.07 | SEC |
| 12 August 2026 | 344 | $247.98 | SEC |
| 7 August 2026 | 24,719 | $256.65 | SEC |
| 4 August 2026 | 91 | $251.58 | SEC |
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.
Read more
Largest in the window: 24,719 on 7 August 2026. A fail is an operational fact about settlement, not a position.Source
Each fund's 13F-HR on EDGAR, linked per row; positions matched to JAZZ by CUSIP from the SEC's own fails-to-deliver files; Schedule 13D and 13G from the company's own filing index, each read to confirm the company is the issuer named.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.